CAMBRIDGE, MA
Allocation by class
Portfolio Concentration
Top 3 weight
69.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 23.01M
Full voting authority
23.01M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc.SOLE | Common Stock | 2.85M | SH | $326.53M 37.05% | 2.85M | 0.00 | 0.00 |
Dyne Therapeutics, Inc.SOLE | Common Stock | 6.80M | SH | $151.03M 17.14% | 6.80M | 0.00 | 0.00 |
Sionna Therapeutics, Inc.SOLE | Common Stock | 3M | SH | $131.78M 14.95% | 3M | 0.00 | 0.00 |
Kailera Therapeutics, Inc.SOLE | Common Stock | 5.17M | SH | $113.92M 12.93% | 5.17M | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | Common Stock | 1.51M | SH | $110.72M 12.56% | 1.51M | 0.00 | 0.00 |
Q32 Bio, Inc.SOLE | Common Stock | 2.72M | SH | $34.62M 3.93% | 2.72M | 0.00 | 0.00 |
Korro Bio, Inc.SOLE | Common Stock | 962.88K | SH | $12.69M 1.44% | 962.88K | 0.00 | 0.00 |